NOVEL SYNTHETIC APPROACHES FOR THE TREATMENT OF MALIGNANT MELANOMA UNDER CLINICAL TRIAL
Tara Shankar Basuri1*, Ishvar Parmar1, Vishal Modi2, Virag Shah3, Niyatee Thakur4
SSR College of pharmacy, Silvassa,
U.T of Dadra & Nagar Haveli-396230
Malignant melanoma is the most lethal form of skin cancer and anincreasingly common disease worldwide. It remains one of the most treatment-refractorymalignancies. The current treatment options for patients with metastatic melanoma arelimited and in most cases non-curative. This review focuses on novel synthetic and herbal drugs for malignant melanoma treatment, by a single or combinational agent approach. These molecules are widely used by the oncologists for the treatment of this type of cancer. So this review can help to the public to aware the malignant melanoma and its treatment and novel target for its treatment.
REFERENCE ID: PHARMATUTOR-ART-1804
Melanoma1 is a cancer that starts in a certain type of skin cell. Melanoma is a cancer that begins in the melanocytes. Other names for this cancer include malignant melanoma and cutaneous melanoma. Because most melanoma cells still make melanin, melanoma tumors are usually brown or black. But some melanomas do not make melanin and can appear pink, tan, or even white. Melanomas2 can occur anywhere on the skin, but they are more likely to start in certain locations. The trunk (chest and back) is the most common site in men. The legs are the most common site in women. The neck and face are other common sites.Skin cancer is usually a result of too much exposure to the sun. While skin cancer is the most common form of cancer, many types are both preventable and treatable. Having darkly pigmented skin lowers your risk of melanoma at these more common sites, but anyone can develop this cancer on the palms of the hands, soles of the feet, and under the nails. Melanomas in these areas account for more than half of all melanomas in African Americans but fewer than 1 in 10 melanomas in whites.
Melanomas can also form in other parts of your body such as the eyes, mouth, and genitals, but these are much less common than melanoma of the skin. Melanoma is much less common than basal cell and squamous cell skin cancers, but it is far more dangerous. Like basal cell and squamous cell cancers, melanoma is almost always curable in its early stages. But it is much more likely than basal or squamous cell cancer to spread to other parts of the body if not caught early.
Figure 1: A Melanoma
Other Skin Cancers
Skin cancers that are not melanomas are sometimes grouped as non-melanoma skin cancers because they develop from skin cells other than melanocytes. They tend to behave very differently from melanomas and are often treated in different ways.
Non-melanoma skin cancers include basal cell and squamous cell cancers. They are by far the most common skin cancers, and actually are more common than any other form of cancer. Because they rarely spread (metastasize) to other parts of the body, basal cell and squamous cell skin cancers are less worrisome and are treated differently from melanoma. Merkel cell carcinoma is an uncommon type of skin cancer that is sometimes harder to treat.
There are five different types of skin cancer:
- Basal cell carcinoma3 is the most common form and accounts for 90% of all skin cancers. It starts in the basal cells, at the bottom of the outer skin layer and is caused by long-term exposure to sunlight. It is the most easily treated.
- Squamous cell carcinoma4 is the second most common type. It starts in the outer skin layer, eventually penetrating the underlying tissue if not treated. It is easily treated when found early, but in a small percentage of cases this cancer spreads to other parts of the body.
- Malignant melanoma is the most serious type of skin cancer5 and is responsible for the most deaths. However, it can be cured if it is diagnosed and removed early. Melanoma starts in moles or other growths on normal skin.
- Kaposi's sarcoma (KS) is caused by a virus in the herpes family. An aggressive AIDS-related form affects about one third of people with AIDS. A more slow-growing form occurs in elderly men of Italian or Jewish ancestry.
Chemotherapy for melanoma skin cancer
Chemotherapy (chemo) uses drugs that kill cancer cells. The drugs are usually injected into avein or taken by mouth as a pill. They travel through the bloodstream to all parts of the bodyand attack cancer cells that have already spread beyond the skin to lymph nodes and otherorgans. Because the drug reaches all areas of the body, it is called a systemic therapy.
Chemo is often used to treat advanced melanoma. Although it is usually not as effective inmelanoma as it is in some other types of cancer, chemo may relieve symptoms or extendsurvival for some patients.
Doctors give chemotherapy in cycles; with each period of treatment followed by a rest periodto allow the body time to recover. Each chemotherapy cycle typically lasts for a few weeks.
Several clinical trials have been done may be used to treat melanoma:
Bernd et al6 found that Bleomycin enhances the tyrosinase activity of human malignant melanoma cells in culture. By application of bleomycin fine pigmentations on basal cell layers will appear in irritated parts of the skin. Therefore we investigated the effect of bleomycin on the tyrosinase activity
Rassnick et al7 found the use of carboplatin for treatment of dogs with malignant melanoma. Carboplatin had activity against macroscopic spontaneously occurring malignant melanomas in dogs and should be considered as an adjunctive treatment for microscopic local or metastatic tumors. Gastrointestinal toxicosis was associated with body weight. Because small dogs are more likely to have adverse gastrointestinal effects, gastrointestinal protectants should be considered for these patients.
Singh et al found that Green Tea8 Catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymaltransition.
Feliu at al9 found treatment of metastatic malignant melanoma with cisplatin plus tamoxifen.
Bill et al found that curcumin10 induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines. Curcumin has potential as a chemopreventative and chemotherapeutic agent, but its interactions with clinically relevant cytokines are poorly characterized.
Pectasides et al11 found the treatment of metastatic malignant melanoma with dacarbazine.
NOW YOU CAN ALSO PUBLISH YOUR ARTICLE ONLINE.
SUBMIT YOUR ARTICLE/PROJECT AT email@example.com
FIND OUT MORE ARTICLES AT OUR DATABASE